Latest News for Marizyme Stock (OTC:MRZM)

Marizyme Inc is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical device technologies that improve patient health outcomes. Currently, the company is focused on developing three medical technology products: DuraGraft, Krillase, and MATLOC. DuraGraft is a single-use intraoperative vascular graft treatment that protects against ischemic injury and reduces the incidence and complications of graft failure, MATLOC is a point-of-care, lab-on-chip digital screening, and diagnostic device platform, initially being developed for quantitative chronic kidney disease, or CKD, assessment, and Krillase protein enzyme provides a therapeutics opportunity for wound healing, thrombosis, and pet health.

Marizyme Inc

<a href="https://asia.nikkei.com/Business/Technology/Microsoft-Google-partner-with-Japanese-cities-on-AI-rules" title="https://asia.nikkei.com/Business/Technology/Microsoft-Google-partner-with-Japanese-cities-on-AI-rules">https://asia.nikkei.com/Business/Technology/Microsoft-Google-partner-with-Japanese-cities-on-AI-rules</a>

News

Politics

General

GOOG

GOOGL

MSFT

'Microsoft, Google partner with Japanese cities on AI rules' -Nikkei Asia Report

<a href="https://www.globenewswire.com/news-release/2024/04/29/2871564/0/en/Chevron-Entry-into-PEL-82.html" title="https://www.globenewswire.com/news-release/2024/04/29/2871564/0/en/Chevron-Entry-into-PEL-82.html">https://www.globenewswire.com/news-release/2024/04/29/2871564/0/en/Chevron-Entry-into-PEL-82.html</a>

Watching Shares Of Chevron; Traders Circulate Release Titled 'Chevron Entry into PEL 82'

WIIM

MBLY

Mobileye shares are trading lower. Citigroup maintained a Buy rating on the stock but lowered its PT to $53. Last week, Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $26 to $25.

Wells Fargo analyst Michael Turrin maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Overweight and lowers the price target from $75 to $65.

Price Target

Analyst Ratings

BRZE

Wells Fargo Maintains Overweight on Braze, Lowers Price Target to $65

Financial giants have made a conspicuous bullish move on Robinhood Markets. Our analysis of options history for Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) revealed 13 unusual trades.
Delving into the details, we found 53% of traders were bullish, while 46% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $219,256, and 8 were calls, valued at $428,662.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $10.0 to $25.0 for Robinhood Markets over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Robinhood Markets options trades today is 10716.75 with a total volume of 4,769.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Robinhood Markets's big money trades within a strike price range of $10.0 to $25.0 over the last 30 days.
<h3>Robinhood Markets Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714414564_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$5.55</td>
<td>$5.35</td>
<td>$5.55</td>
<td>$20.00</td>
<td>$166.5K</td>
<td>31.1K</td>
<td style="text-align: right;">613</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$1.12</td>
<td>$1.1</td>
<td>$1.11</td>
<td>$17.50</td>
<td>$71.9K</td>
<td>737</td>
<td style="text-align: right;">231</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/24/24</td>
<td>$1.12</td>
<td>$0.93</td>
<td>$0.94</td>
<td>$19.50</td>
<td>$67.4K</td>
<td>2.0K</td>
<td style="text-align: right;">630</td>
</tr>
<tr>
<td>HOOD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$1.38</td>
<td>$1.36</td>
<td>$1.36</td>
<td>$17.00</td>
<td>$51.0K</td>
<td>3.2K</td>
<td style="text-align: right;">392</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$1.79</td>
<td>$1.75</td>
<td>$1.75</td>
<td>$20.00</td>
<td>$42.1K</td>
<td>12.9K</td>
<td style="text-align: right;">492</td>
</tr>
</tbody>
</table>

<h3>About Robinhood Markets</h3>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fractional shares, recurring investments, and IPO Access. It earns transaction-based revenues from routing user orders for options, equities, and cryptocurrencies to market makers when a routed order is executed.
In light of the recent options history for Robinhood Markets, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Robinhood Markets</h3>
<ul>
<li>With a volume of 5,658,517, the price of HOOD is down -1.51% at $17.61. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 9 days.</li>
</ul>
<h3>Expert Opinions on Robinhood Markets</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $19.8.
<ul>
<li>Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Robinhood Markets with a target price of $18. </li>
<li>An analyst from JMP Securities has decided to maintain their Market Outperform rating on Robinhood Markets, which currently sits at a price target of $28. </li>
<li>An analyst from Piper Sandler persists with their Neutral rating on Robinhood Markets, maintaining a target price of $17. </li>
<li>Maintaining their stance, an analyst from Goldman Sachs continues to hold a Neutral rating for Robinhood Markets, targeting a price of $20. </li>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Underweight rating for Robinhood Markets, targeting a price of $16. </li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Robinhood Markets options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Markets

HOOD

This Is What Whales Are Betting On Robinhood Markets

Financial giants have made a conspicuous bullish move on Chevron. Our analysis of options history for Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) revealed 21 unusual trades.
Delving into the details, we found 52% of traders were bullish, while 38% showed bearish tendencies. Out of all the trades we spotted, 9 were puts, with a value of $485,809, and 12 were calls, valued at $379,972.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $185.0 for Chevron, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In terms of liquidity and interest, the mean open interest for Chevron options trades today is 3535.5 with a total volume of 7,812.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Chevron's big money trades within a strike price range of $100.0 to $185.0 over the last 30 days.
<h3>Chevron Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714414558_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.15</td>
<td>$165.00</td>
<td>$126.0K</td>
<td>816</td>
<td style="text-align: right;">468</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$20.95</td>
<td>$20.55</td>
<td>$20.55</td>
<td>$185.00</td>
<td>$90.4K</td>
<td>3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$4.3</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$165.00</td>
<td>$53.5K</td>
<td>1.2K</td>
<td style="text-align: right;">312</td>
</tr>
<tr>
<td>CVX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.35</td>
<td>$8.25</td>
<td>$8.35</td>
<td>$160.00</td>
<td>$50.9K</td>
<td>3.8K</td>
<td style="text-align: right;">367</td>
</tr>
<tr>
<td>CVX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$12.05</td>
<td>$12.0</td>
<td>$12.05</td>
<td>$165.00</td>
<td>$44.5K</td>
<td>1.6K</td>
<td style="text-align: right;">38</td>
</tr>
</tbody>
</table>

<h3>About Chevron</h3>
Chevron is an integrated energy company with exploration, production, and refining operations worldwide. It is the second-largest oil company in the United States with production of 3.1 million of barrels of oil equivalent a day, including 7.7 million cubic feet a day of natural gas and 1.8 million of barrels of liquids a day. Production activities take place in North America, South America, Europe, Africa, Asia, and Australia. Its refineries are in the US and Asia for total refining capacity of 1.8 million barrels of oil a day. Proven reserves at year-end 2023 stood at 11.1 billion barrels of oil equivalent, including 6.0 billion barrels of liquids and 30.4 trillion cubic feet of natural gas.
Having examined the options trading patterns of Chevron, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Chevron's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,609,065, with CVX's price up by 0.32%, positioned at $166.42.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 88 days.</li>
</ul>
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Chevron options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Looking At Chevron's Recent Unusual Options Activity

High-rolling investors have positioned themselves bullish on Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in TER often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 8 options trades for Teradyne. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 37% bearish. Among all the options we identified, there was one put, amounting to $28,860, and 7 calls, totaling $624,727.
<h3>What's The Price Target?</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $95.0 to $130.0 for Teradyne during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Teradyne's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teradyne's whale trades within a strike price range from $95.0 to $130.0 in the last 30 days. 
<h3>Teradyne Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714414552_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$5.2</td>
<td>$4.7</td>
<td>$4.8</td>
<td>$130.00</td>
<td>$360.0K</td>
<td>253</td>
<td style="text-align: right;">761</td>
</tr>
<tr>
<td>TER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$38.7</td>
<td>$36.3</td>
<td>$36.4</td>
<td>$95.00</td>
<td>$58.2K</td>
<td>141</td>
<td style="text-align: right;">16</td>
</tr>
<tr>
<td>TER</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$7.5</td>
<td>$7.4</td>
<td>$7.4</td>
<td>$110.00</td>
<td>$55.5K</td>
<td>1.2K</td>
<td style="text-align: right;">80</td>
</tr>
<tr>
<td>TER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$7.8</td>
<td>$7.6</td>
<td>$7.8</td>
<td>$110.00</td>
<td>$39.0K</td>
<td>1.2K</td>
<td style="text-align: right;">355</td>
</tr>
<tr>
<td>TER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$7.6</td>
<td>$7.5</td>
<td>$7.6</td>
<td>$110.00</td>
<td>$38.0K</td>
<td>1.2K</td>
<td style="text-align: right;">255</td>
</tr>
</tbody>
</table>

<h3>About Teradyne</h3>
Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Following our analysis of the options activities associated with Teradyne, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Teradyne</h3>
<ul>
<li>Trading volume stands at 856,237, with TER's price up by 2.49%, positioned at $116.97.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 86 days.</li>
</ul>
<h3>Expert Opinions on Teradyne</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $117.6.
<ul>
<li>Consistent in their evaluation, an analyst from Susquehanna keeps a Positive rating on Teradyne with a target price of $130. </li>
<li>Maintaining their stance, an analyst from Baird continues to hold a Outperform rating for Teradyne, targeting a price of $120. </li>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Neutral, adjusting the price target to $110. </li>
<li>An analyst from Goldman Sachs has decided to maintain their Neutral rating on Teradyne, which currently sits at a price target of $118. </li>
<li>An analyst from JP Morgan persists with their Neutral rating on Teradyne, maintaining a target price of $110. </li>
</ul>
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Teradyne with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

A Closer Look at Teradyne's Options Market Dynamics

Wells Fargo analyst Gary Mobley maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Overweight and raises the price target from $100 to $115.

Wells Fargo Maintains Overweight on ARM Holdings, Raises Price Target to $115

BofA Securities&nbsp;analyst Robert F. Ohmes cut&nbsp;Dick&#8217;s Sporting Goods, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) price target to $225 (from $245) while&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/DKS/analyst-ratings" rel="noreferrer noopener">reiterating a Neutral rating</a>.
The price target change reflects the risk of more limited earnings upside this year as the analyst expects planned investment spending supporting the growth of House of Sport (+75-100 by 2027), Next Generation stores (+16 in 2024), and GameChanger (technology capabilities build-out)&nbsp;to weigh on occupancy and operating expenses.
The analyst cut the estimates for first-quarter adj. EPS to $2.85 (from $2.97) to reflect better SG&amp;A pressures in the quarter, given brand campaigns, higher pre-opening&nbsp;and&nbsp;marketing expenses to support House of Sport openings, and continued shrink pressures on gross margin.
On the other hand, the analyst&#8217;s adjusted EPS estimate of $13.20 reflects modest SG&amp;A leverage on cost management and business optimization actions completed in the fourth quarter.
Meanwhile, Ohmes sees impressive DKS House of&nbsp;Sport&nbsp;stores, all-time high-key brand partnerships, DKS vertical apparel brands (CALIA, VRST, DSG), and sourcing capabilities as tailwinds.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37755989/dicks-sporting-goods-to-gain-from-diverse-assortment-of-national-brands-rollout-of-" rel="noreferrer noopener">Dick&#8217;s Sporting Goods To Gain From Diverse Assortment Of National Brands, Rollout Of New Store Concepts: Analyst</a>
Price Action: DKS shares are down 1.62% at $203.78 at the last check Monday.
Photo via Wikimedia Commons

Analyst Color

Equities

Large Cap

Reiteration

Trading Ideas

Dick's Sporting Goods' Investment Spree Could Spoil The Game For Investors, Analyst Says

U.S. stocks kicked off the week on a positive note, with all major averages edging higher in anticipation of significant events including earnings reports from tech giants like Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) on Tuesday and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) on Thursday, a pivotal Federal Reserve Open Market Committee meeting on Wednesday, and the April&#8217;s <a href="https://www.benzinga.com/topic/labor-market">jobs report on Friday.</a>
The S&amp;P 500 rose 0.2% by midday trading in New York, following a 1% surge last Friday. Both the tech-heavy Nasdaq 100 and blue-chip stocks in the Dow Jones made similar gains. 
Small caps, as tracked by iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), outperformed large-cap stocks, rising as much as 0.9%. 
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) grabbed the market spotlight by securing a significant partnership with Chinese search engine giant Baidu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NYSE">BIDU</a>), which granted the Elon Musk-led company access to its mapping license for data collection <a href="https://www.benzinga.com/news/24/04/38491516/teslas-model-3-and-model-y-clear-chinas-data-security-hurdle-fsd-software-deployment-nears">on China&#8217;s public roads. </a> 
The deal removes a last regulatory barrier for Tesla&#8217;s driver assistance system, known as Full Self-Driving (FSD), to be introduced in China. Shares of Tesla rose as much as 16% Monday. 
The Bank of Japan sent shockwaves through the forex exchange market by intervening to support the value of the Japanese yen, which had plummeted to as low as <a href="https://www.benzinga.com/markets/asia/24/04/38494691/japan-intervenes-to-support-struggling-yen-why-did-it-trigger-nikkei-225-dip-4-charts-to-watch">160 per dollar overnight.</a> This action spurred a significant reversal in the USD/JPY exchange rate, plunging to as low as 155 by 1 p.m. ET.
In the commodities market, natural gas prices jumped by nearly 7% on improved demand forecasts, with the U.S. Henry Hub futures surpassing $2 per million British thermal units. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) was 0.5% lower, on track to notch a six-day losing streak. 
<h1 class="wp-block-heading">Monday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices &amp; ETFs</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,020.94</td>
<td>0.8%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,357.10</td>
<td>0.3%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,770.47</td>
<td>0.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,112.21</td>
<td>0.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:00 p.m. EDT</figcaption></figure>
The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.3% to $509.73, the&nbsp;SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.3% to $383.49 and the tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) inched 0.2% up to $432.31, according to&nbsp;<a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.&nbsp;
Sector-wise, the Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 2.3%, followed by the Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>), up 1.5%. The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) was the major laggard, down 1%.
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul>
<li>Lithium miners rallied on strong EV momentum, with Arcadium Lithium plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>), Piedmont Lithium Inc. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLLTL#OTC">PLLTL</a>) and Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>) up 16%, 10% and 7%, respectively.</li>
<li>AMC International Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) fell 10.8% on weaker first-quarter preliminary results. </li>
<li>SoFi Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>) fell 10% as second-quarter revenue guidance missed Street&#8217;s forecasts. </li>
<li>Other stocks reacting to earnings were ON Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) up 3.3%, Dominos Pizza Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) up 6%, Revvity Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVTY#NYSE">RVTY</a>) up 3.8%, Franklin Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) down over 6%, </li>
<li>Deciphera Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCPH#NASDAQ">DCPH</a>) saw its shares soar by 73% to $25.36 following the announcement of its acquisition by ONO Pharmaceutical for $25.60 per share in cash.</li>
<li>Soleno Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNO#NASDAQ">SLNO</a>) witnessed a 31.1% surge in its shares to $49.66 after the company revealed it had been granted Breakthrough Therapy Designation from the FDA for DCCR extended-release tablets in the treatment of Prader-Willi Syndrome. </li>
<li>Notable names reporting after the close are F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>), Everest Group, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>), NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>), Lattice Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>), MicroStrategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARAA#NASDAQ">PARAA</a>), Qiagen NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>), Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>), Sanmina Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>) and Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>).</li>
</ul>
Read Now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38497224/ai-data-centers-drive-electricity-demand-goldman-sachs-picks-16-stocks-to-play-the-">AI Data Centers Drive Electricity Demand: Goldman Sachs Picks 16 Stocks To Play The Trend</a>
Photo: Shutterstock

Earnings

Earnings Beats

Earnings Misses

Mid Cap

Broad U.S. Equity ETFs

Commodities

Forex

Global

Tech

ETFs

$BTC

AAPL

ALTM

AMZN

BIDU

DCPH

SPDR Dow Jones Industrial Average ETF Trust

FFIV

LSCC

MSTR

NXPI

PARA

PARAA

PLLTL

QGEN

RMBS

RVTY

SANM

SLNO

SOFI

TSLA

Select Sector SPDR-Consumer Discretionary

YUMC

US Stocks Kick Off The Week In The Green, Tesla Rockets On China's FSD Approval, Yen Rallies: What's Driving Markets Monday?

Wells Fargo analyst Roger Read maintains Halliburton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>) with a Overweight and lowers the price target from $50 to $49.

Wells Fargo Maintains Overweight on Halliburton, Lowers Price Target to $49

Wells Fargo analyst Colin Langan maintains AutoNation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>) with a Equal-Weight and raises the price target from $153 to $169.

Wells Fargo Maintains Equal-Weight on AutoNation, Raises Price Target to $169

Wells Fargo analyst Stephen Baxter maintains Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) with a Equal-Weight and lowers the price target from $17 to $15.

TDOC

Wells Fargo Maintains Equal-Weight on Teladoc Health, Lowers Price Target to $15

Boeing Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>)&nbsp;is set&nbsp;to embark on a bond sale, aiming to raise $10 billion amid challenges like a recent quarterly loss and Moody&#8217;s credit rating downgrade.&nbsp;
Moody&#8217;s downgrade, which leaves Boeing&#8217;s credit rating just a step above junk, underscores the company&#8217;s current financial strain.&nbsp;
S&amp;P rated them BBB- and Moody&#8217;s&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38418530/boeing-isnt-junk-status-yet-moodys-outlook-on-aircraft-maker-goes-negative" rel="noreferrer noopener">rated them Baa3</a>.&nbsp;The issuance consists of maturities ranging from three to 40 years, with the&nbsp;longer-term bonds&nbsp;carrying&nbsp;a yield&nbsp;of 2.25&nbsp;percentage points higher than Treasuries, significantly lower than initial estimates.
Boeing&#8217;s Chief Financial Officer, Brian West,&nbsp;<a target="_blank" href="https://www.bloomberg.com/news/articles/2024-04-29/boeing-looks-to-sell-bonds-after-reporting-cash-burn?srnd=markets-vp" rel="noreferrer noopener">stressed</a>&nbsp;the company&#8217;s commitment to safeguarding its investment-grade rating, Bloomberg highlighted.
With access to $10 billion in untapped credit lines and focused on prudently managing its balance sheet, Boeing remains determined to prioritize its financial stability.
Related:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38404308/boeings-737-saga-dents-q1-bottomline-ceo-emphasizes-improving-quality-safety" rel="noreferrer noopener">Boeing&#8217;s 737 Saga Dents Q1 Bottomline, CEO Emphasizes Improving Quality &amp; Safety</a>.
The warm investor reception the deal is getting &#8220;may say more about strong demand for new issuance than the prospects for Boeing credit,&#8221; Bloomberg noted, citing a&nbsp;portfolio manager at&nbsp;Brandywine Global Investment Management.
Despite the challenges, analysts like Matthew Geudtner from Bloomberg Intelligence believe Boeing possesses the necessary tools to defend its investment-grade status.&nbsp;
The negative outlook from credit rating agencies gives Boeing at least 12 months to demonstrate progress in streamlining operations and adhering to FAA production regulations.
Financial institutions, including Citigroup Inc., Bank of America Corp., JPMorgan Chase &amp; Co., and Wells Fargo &amp; Co.,&nbsp;are managing&nbsp;the bond deal.&nbsp;
Reuters noted that investors and analysts suggest Boeing may issue bonds to address over&nbsp;$12 billion&nbsp;in debt due in 2025 and 2026.&nbsp;
Moody&#8217;s noted Boeing&#8217;s resilient business profile offsets the struggles in commercial aircraft, which&nbsp;are expected&nbsp;to persist until 2026.&nbsp;
Bond proceeds will enhance Boeing&#8217;s liquidity before existing debt matures, including $4.3 billion due in 2025, Reuters added.
Sources indicate strong demand for the bonds, with subscriptions reportedly eight times oversubscribed.
Price Action:&nbsp;BA shares are up 3.37% at $172.86&nbsp;at&nbsp;the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo via Wikimedia Commons

Financing

Movers

Boeing To Raise $10B Via Bond Sale Amid Credit Rating Downgrade - Will Investors Show Confidence?

Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) with a Equal-Weight and lowers the price target from $410 to $375.

Wells Fargo Maintains Equal-Weight on Molina Healthcare, Lowers Price Target to $375

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) with a Underweight and lowers the price target from $96 to $94.

Wells Fargo Maintains Underweight on Cardinal Health, Lowers Price Target to $94

Wells Fargo analyst Chris Carey maintains Newell Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWL#NASDAQ">NWL</a>) with a Equal-Weight and raises the price target from $7 to $8.

Wells Fargo Maintains Equal-Weight on Newell Brands, Raises Price Target to $8

&nbsp;- Reuters Citing California New Car Dealers Association

Tesla's Q1 Registrations Fell 7.8% In California

Wells Fargo analyst Chris Carey maintains Colgate-Palmolive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) with a Equal-Weight and raises the price target from $90 to $92.

Wells Fargo Maintains Equal-Weight on Colgate-Palmolive, Raises Price Target to $92

Wells Fargo analyst Gabe Hajde maintains AptarGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) with a Overweight and raises the price target from $160 to $163.

Wells Fargo Maintains Overweight on AptarGroup, Raises Price Target to $163

Marizyme Incorporated (MRZM) has released an update to notify the public and investors about its officers. Julie Kampf has resigned from her positi...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Marizyme Stock (OTC:MRZM)

Friday, January 17, 2020

Thursday, September 27, 2018